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A. Introduction 
Chikungunya fever (CHIK) is an emerging, mosquito-borne 
disease caused by an alphavirus, Chikungunya virus (CHIKV). 
The disease is transmitted predominantly by Aedes aegypti and 
Ae. Albopictus mosquitoes, the same species involved in the 
transmission of dengue. 
Traditionally, CHIKV epidemics have shown cyclical trends, with 
inter-epidemic periods ranging from 4 to 30 years. Since 2004, CHIKV has expanded its 
geographical range, causing sustained epidemics of unprecedented magnitude in Asia 
and Africa. Although areas in Asia and Africa are considered to be endemic for the 
disease, the virus produced outbreaks in many new territories in the Indian Ocean 
islands and in Italy. This recent reemergence of CHIKV has heightened the world’s 
public health awareness and concern about this virus. 
Although indigenous transmission of CHIKV does not occur in the Americas now, the 
risk for its introduction into local vector mosquito populations is likely higher than had 
previously been thought, especially in tropical and subtropical areas where Ae. aegypti, 
one of the main vectors of CHIKV, has a broad distribution. There is an intense 
travel/cultural exchange between the Caribbean and Chikungunya virus (CHIKV) 
endemic countries, such as India and other Asian countries. This fact put the Caribbean 
as one of the most vulnerable sub-regions in the Americas.  
Most of the countries and other territories in this sub-
region of the Americas are relatively small islands, which 
makes disease containment a possibility. The 
effectiveness of these measures will depend on the early 
detection and diagnosis of indigenous CHIKV 
transmission. Aggressive vector control coupled with 
quarantine (i.e., travel restrictions) has the potential to 
limit the spread of CHIKV in the Region.  
Given these factors, the Pan American Health Organization (PAHO), with the support of 
the Division of Vector-Borne Diseases of the United States Centers for Disease Control 
and Prevention (DVBD, CDC), supported the first Caribbean Sub-regional training 
workshop for Preparedness and Response for Chikungunya Virus Introduction in the 
Americas in the context of dengue (Annex 1: Agenda).  
With participants from 22 countries, including clinicians, vector control teams and 
laboratory technicians, the objective of the meeting was to train public health staff from 
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the Caribbean countries on the detection, diagnosis, clinical management, and 
prevention of Chikungunya (CHIK) and dengue (DEN) viruses’ infections.  
The objective of the meeting was to raise the capacity of Caribbean countries’ health 
systems for the timely identification of CHIK outbreaks in the context of other epidemic 
prone diseases, such as dengue.  
Experts from France, USA, Puerto Rico, Colombia, and El 
Salvador gave training in clinical management of CHIK cases, 
laboratory diagnostic, risk communication and vector control. 
As one of the products of the meeting, the participants 
elaborated a draft preparedness, control, and response plan for 
CHIK outbreaks in the Caribbean sub-region, focused in 3 main 
components clinical management and epidemiology, laboratory 
diagnostic and vector control. 
 
B. Immediate Actions to be taken 
The participants of the meeting suggested that, in order to make this plan effective, the 
following actions should be taken:  
 PAHO will communicate with Ministries of Health to convey the importance of 
preparing for the introduction of CHIK. 
  
 Participants of the training course will promote sensitization of Senior Health 
Staff at the country level (Minister, CMO, PS). 
 Each country Ministry of Health will review existing plans and develop country-
specific programs based on the framework developed at meeting. 
 Each country Ministry of Health will evaluate the capacity of current dengue 
surveillance and response programs as a background for CHIKV introduction. 
 
For more information about CHIKV please consult the:  “Preparedness and 
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C. Framework for Preparedness Plan for 
CHIK Outbreak Control 
 
1. CLINICAL MANAGEMENT 
Expected Result Indicators 
 
Patient care services 
of the Caribbean Sub-
region prepared for 
early detection and 
reporting of suspected 




 100% of countries in the Caribbean Sub-region with CHIK 
preparedness plan adapted to their health system.  
 Number of suspected CHIKV cases detected and reported 
according to IHR.  
 100% of all stakeholders informed about CHIK preparedness plan 
and a core group of leaders trained in the management of CHIK 
cases within 1 year.  
 100% of countries with a contingency plan for organization of 
health services.  
 




Phase 1: Preparedness 
  




for CHIK outbreaks  
a. Read and then discuss the Caribbean 
Sub-region preparedness plan for CHIK 
outbreaks with the MOH and medical 
leaders, and then discuss plan with the 
national emergency committee.  
CMO/Public health 
designee 
b. Create national preparedness plan for 
CHIK outbreaks according to the country 
situation with the input from all 
stakeholders.   
Public health officials 
National health 
disaster coordinators 
c. Disseminate the preparedness plan for 
CHIK outbreaks to stakeholders. 
CMO 
Public health officials 
2. Training for clinical 
staff on all aspects 
of CHIK 
management.  
a. Organize training for all healthcare 
providers/professionals on the 
management of suspected CHIK cases. 
Consider training on CHIK when giving 
seasonal updates on the management of 
dengue.  
Experts 
Clinicians trained on 
CHIK guidelines 
Public Health officials 
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b. Organize workshops for public health 
officials and personnel at all points of 
entry to include quarantine and 
immigration officials about the CHIK 
preparedness plan and compliance with 
IHR regulations.  
Public Health officials 














1. Organize patient 
care services 
a. Determine and establish the baseline 
infrastructure of healthcare facilities to 
support a CHIK outbreak.  
CMO, PS, Medical 
Directors, Public 
Health Officials 
b. Review and adapt the patient care 
protocol and create a critical route 
flowchart of CHIK patients.  
CMO, Senior 
Clinicians 
c. Conduct triage to optimize resources and 
reduce morbidity in high risk patients 
(pregnant women, underlying diseases, 
elderly) 
Trained health care 
professionals 
d. Mobilize additional resources 
(medication, bed nets, personnel, 
transportation) as necessary. 
CMO, PS 
Public Health officials 
National Disaster 
Leaders 
PHASE 3: End of the 
outbreak 
1. Analyze the actions 
taken during the 
outbreak 
a. Maintain the monitoring and evaluation 
activities.  
b. Conduct after-action evaluations to 
identify and remedy gaps in the country 




CAREC, CDC- Puerto 
Rico, CDC Fort 
Collins, Pasteur 
Institute. 
IHR national focal 
point 
PAHO 
PHASE 4: Endemic 
seasonal 
transmissions  
1. Maintain the 
surveillance 
activities 
a. Establish a regular, integrated 
surveillance program. 
b. Re-visit activities in Phase 1 to assure 
preparedness is maintained. 
MOH 
IHR national focal 
point 
PAHO 
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2. EPIDEMIOLOGIC SURVEILLANCE  
Expected Result Indicators 
CHIK Epidemiological 
Surveillance system for 
timely alert and opportune 
response implemented. 
 CHIK surveillance systems in place (e.g., Lab data, clinical 
data, entomological data)  
 Number of sites at the country level with the information about 
CHIKV 
 100% of CHIK outbreaks reported according to IHR guidelines.  
 




Phase 1: Preparedness  
 
1. Strengthen the 
epidemiological 
surveillance system for 




a. Include CHIK as part of Disease 
Surveillance System – Class 1 disease 
(reported within 24hrs of suspicion). 
b. Standardize a CHIK case definition 
(clinical and epidemiological) based on 
PAHO-CDC guidelines. 
c. Set up clinical and epidemiological 
surveillance in the countries Caribbean 
Sub-region. 
d. Standardize the methods used to 
determine the criteria (clinical, 
epidemiological and laboratory) to 
confirm the start of a CHIK outbreak in 






clinical, laboratory)  





of the beginning of an 
outbreak 
 
a. Classify cases as locally-acquired or 
imported cases. 
b. Notify the National and international 
Epidemiological Focal Points according 
to IHR. 
c. Enhance clinical and epidemiological 
surveillance system in the countries of 




2. Monitor and assess the 






a. Activate and maintain the national and 
regional situation rooms/coordination 
mechanisms. 
b. Establish routine communication 
mechanisms with relevant national and 
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of experts (clinical, laboratory, 
epidemiology, vector and outbreak 
response). 
c. Analyze and interpret weekly data and 
develop a daily and weekly outbreak 
report.  
d. Provide support and technical 
assistance to affected countries. 
PAHO, CAREC, 
CDC and other 
countries  
 
PHASE 3: End of the 
outbreak 
2. Analyze the actions 
taken during the 
outbreak 
c. Maintain the monitoring and evaluation 
activities.  
d. Conduct after-action evaluations to 
identify and remedy gaps in the country 





Puerto Rico, CDC 
Fort Collins, Pasteur 
Institute. 
IHR national focal 
point 
PAHO 
PHASE 4: Endemic 
seasonal transmissions  
2. Maintain the surveillance 
activities 
c. Establish a regular, integrated 
surveillance program. 
d. Re-visit activities in Phase 1 to assure 
preparedness is maintained. 
MOH 
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3. LABORATORY COMPONENT 
Expected Result Indicators 




investigation for a 
timely response to 
clinicians and public 
health officials. 
 
 Number of laboratories referring samples of CHIK suspected cases 
to CAREC & CDC 
 Number of laboratories that have access to molecular testing 
through reference laboratories for CHIKV diagnostic. 
 Number of laboratories participating in external quality control 
programs for CHIK diagnostic  
 
LAB Activities Tasks 
Responsible Persons/ 
Organizations 
PHASE 1: Preparedness 
1. Establish 
communication 
channels within the 
national authorities. 
 
a. Establish a lab team: define the roles and 
responsibilities of the staff in 
preparedness for a CHIK outbreak. 
b. Establish the communication channels 
within the national lab network and outside 
the lab (clinicians, epidemiologist and 
public health) in the country. 
c. Set up communication between the lab, 
the MOH and the IHR National focal point 
in the country. This is the official channel 
to contact international experts to support 
an outbreak. 
d. Harmonize the plan between hospitals, 
clinicians, public health, vector control and 
social communication.  
e. Run a simulation exercises for the whole 
country. 
Ministry of Health  
Chief of the National 
Laboratory  
 




reagents for CHIKV 
diagnosis. 
a. Mobilize funding from national & 
international sources. 
b. Establish a triage of how many samples 
will be tested. 
c. Prepare the logistics for procurement and 
distribution of supplies, sample collection 
and sample transport internally and 
internationally. 
d. Establish agreements with reference labs 
to identify where  the samples will be sent 
(CAREC/CDC- Puerto Rico/CDC Fort 
Collins/ Pasteur  Institute) 
National Laboratory 
Reference Lab: 
CAREC, CDC- Puerto 
Rico, CDC Fort Collins, 
Pasteur Institute. 
PAHO 
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LAB Activities Tasks 
Responsible Persons/ 
Organizations 
e. Ensure reference laboratories maintain 
adequate stock of reagents, supplies and 
equipment for CHIKV diagnosis. 
3. Training workshops 
for CHIV testing 
a. Conduct workshops for training in 
performance of CHIKV diagnostic tests in 
a reference lab and replicate this training 
in the national lab. 
b. Set up the CHIKV testing capacity in 
laboratories (ELISA test, PCR, PRNT as 
appropriate for the laboratory capacity).  
Evaluate laboratory performance with 
external proficiency tests and internal 
quality control. 
c. Prepare and conduct a yearly proficiency 
test for the national and reference 
participant’s labs. 
d. Ensure that appropriate diagnostic tests 
are available to identify other diseases in 
the differential diagnosis, depending on 
the country and clinical presentation 
(undifferentiated febrile syndromes: 
malaria, dengue, leptospirosis, West Nile.) 
See Table 3 in the CHIKV guideline. 
Reference Lab: 
CAREC, CDC- Puerto 






PHASE 1A: First 
suspected case 
1. Detection, sampling 
& report of the first 
suspected cases 
a. Physicians  report suspect cases to the 
public health, epidemiology and lab 
departments 
b. Review case reports do determine if 
imported or local case, in order to select 
the appropriate test algorithm. 
c. Ensure that required information is 
provided with sample (clinical-
epidemiological information, days post 
onset of fever/severe joint pain, travel 
information). 
d. Ensure the correct sample is provided to 
the laboratory (serum) and request a 
second sample to provide paired sera 
(acute and convalescent) to allow 
confirmation of test results.   
e. Aliquot the sample, ensure enough 
volume for the entire test algorithm is sent 
to a reference lab, with all of the required 
case information, to allow independent 
confirmation of results.  




CAREC, CDC- Puerto 
Rico, CDC Fort Collins, 
Pasteur Institute. 
IHR national focal point 
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LAB Activities Tasks 
Responsible Persons/ 
Organizations 
for shipping and that archived specimens 
are appropriately stored. .Notify the 
reference lab  about sample shipment and 
the priority  
g. Test suspected case samples in the lab 
the sample for dengue, leptospirosis, 
malaria and CHIKV 
h. Report the results to the physician, 
epidemiology and public health 
departments. 
i. Report confirmed and presumptive CHIKV 
positive test results to PAHO through the 
IHR national focal point the suspected 
case. 
 
PHASE 2: Established 
outbreak 
1. Test selected 
samples 
a. Establish a triage of how many samples 
will be tested. 
b. Test all hospitalized severe cases  
c. Test all fatal cases (heart blood).  
d. Appropriately prepare and store samples 
that will not be tested immediately, and 
assure that  all clinical epidemiological 
data are available for the samples 





CAREC, CDC- Puerto 
Rico, CDC Fort Collins, 
Pasteur Institute. 
IHR national focal point 
PHASE 3: End of the 
outbreak 
3. Analyze the actions 
taken during the 
outbreak 
e. Maintain the monitoring and evaluation 
activities   
f. Conduct after-action evaluations to 
identify and remedy gaps in the country 




CAREC, CDC- Puerto 
Rico, CDC Fort Collins, 
Pasteur Institute. 
IHR national focal point 
PAHO 
PHASE 4: Endemic 
seasonal transmissions  
3. Maintain the 
surveillance 
activities 
e. Establish a regular surveillance (Lab and 
epidemiology) program 
f. Ensure adequate supply of laboratory 
reagents, review laboratory quality control 
results, conducted needed training. 
g. Re-visit activities in Phase 1 to assure 




CAREC, CDC- Puerto 
Rico, CDC Fort Collins, 
Pasteur Institute. 




10 | P a g e  
 
4. VECTOR CONTROL COMPONENT 









 IVM organization structure is functional and supported.  
 Number of training courses in IVM delivered.  
 100% availability of training manuals developed and adapted to the 
country level 
 Baseline data of Entomological indicators in all regions  
 













a. Review the legislative framework for vector 
control and breading sites control in the civil 
population. 
b. Increase country co-operation for Vector 
Control. 
c. Forge Strong communication links with Public 
Health/ Clinicians/ Epidemiology/ Education 
and Promotion. 
d. Review Vector Surveillance System against 
set objectives 
 Install a good Data Collection routine with 
the ability to make decisions in an 
appropriate and timely manner. 
 Determine frequency of survey eg. every 
3 month  
 Determine sampling framework. 
 Identify key containers and key premises. 
e. Determine hotspots for CHIK/dengue 
transmission based on High Aedes aegypti 
infestation levels, Ecological indicators & 
Epidemiological data. 
f.  Implement control measures in a no CHIK 
and low dengue scenario including 
Community Mobilization/Education and 
source reduction/Larval control. 
g. Establish Inventory Management System for 
Ministry of Health  
Chief of the National 
Vector control unit 
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Vector Activities Tasks Responsible 
Persons/ 
Organizations 
vector control including inventory of Chemical, 
Equipment and Resource. 
h. Conduct training workshops for staff (based 
on identified gaps).  
i. Develop vector control response and 
communication plan, describing increasing 
control activities based on epidemiological 
situation. 
j. Implementation routine Insecticide Resistance 
Monitoring Program with CAREC support. 
k. Establish collaboration mechanism with 
stakeholders eg. Solid Waste management.  




a. Activate Emergency Response Plan 
based on epidemiological situation  
b. Notify entire system and put system on 
alert 
c. Implement enhanced vector control  in 
areas with transmission based on 
entomological and epidemiological data 
Ministry of Health  
Chief of the National 





a. Expand adulticide  applications and larval 
management programs in identified 
transmission  hotspots 
 
Ministry of Health  
Chief of the National 
Vector control unit 
PHASE 3: End of the 
outbreak &  




a. Re-visit activities in Phase 1 to assure 
preparedness is maintained. 
Ministry of Health  
Chief of the National 
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Caribbean Sub-regional Training Workshop 
 
Introducing the new guidelines: 
Preparedness and Response for Chikungunya Virus Introduction in the 




The Jamaica Pegasus Hotel, Kingston, Jamaica 













 Using the new Chikungunya (CHIK) guidelines, train public health staff from the 
Caribbean countries on the detection, diagnosis, clinical management, and prevention 





1. Initiate the implementation in the Caribbean subregion of the new guidelines:  
Preparedness and Response for Chikungunya Virus introduction in the Americas.  
2.  Implement the new dengue clinical management guidelines in Caribbean countries. 
3. Train health care workers in the health services (clinicians, nurses and epidemiologists) 
to respond and cope with outbreaks by CHIK and DEN viruses. 
4. Elaborate country-specific draft preparedness, control, and response plan for CHIK 





 This is one of the “train the trainers” workshops on the new guidelines: “Preparedness 
and response for Chikungunya Virus Introduction in the Americas” . This activity has 
already been carried out in other sub-regions of the Americas. The same methodology 
used in previous sub-regions will be applied, which is based on the contents of the new 
CHIKV guidelines. 
 To raise the capacity of Caribbean countries’ health systems for the timely identification 
of CHIK outbreaks in the context of other epidemic prone diseases, such as dengue. The 
Caribbean sub-region is the most vulnerable in the Americas for Aedes aegypti 
transmitted diseases because of high vector infestation rates, and fragile and 
unprepared health systems. 
  There is an intense travel/cultural exchange between the Caribbean and CHIK endemic 
countries, such as India and other Asian countries.  
 Most of the countries and other territories in this sub-region of the Americas are 
relatively small islands, which makes disease containment a possibility. Aggressive 
vector control coupled with quarantine (i.e., travel restrictions) has the potential to limit 
the spread of CHIK in the Region. The effectiveness of these measures will depend on 
the early detection and diagnosis of indigenous CHIKV transmission. 
 The participation of the Dengue Branch and the Arboviral Diseases Branch of the CDC 
Division of Vector Borne Diseases in this workshop constitutes an opportunity to 
promote the technical cooperation between the CDC’s two WHOCCs and Caribbean 
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Countries leading to improvement of arbovirus surveillance, prevention, diagnosis, and 
outbreak response capacities. 
 
 
Expected Results (Workshop Outcomes) 
 
1. National multidisciplinary health teams provided knowledge to identify CHIKV 
introductions in the context of endemic dengue. 
2. Healthcare services organized to respond to outbreaks and health care workers able to 
manage patients with CHIK.  
3. Training manual for CHIK distributed. 
4. Country-specific draft response plans for CHIK preparedness, outbreak control, and 



































Monday, May 28, 2012 - CHIKUNGUNYA 
HOUR  ACTIVITY Lecturer 
08h00min-8h30min REGISTRATION  
08h30min-9h00min Inauguration ceremony 
 Welcome words by Dr. Margareta Sköld Representative, Jamaica PAHO/WHO. 
 Acknowledgment words by Dr. Roger Nasci, Chief CDC-Fort Collins, USA 
 Official  inauguration of the meeting by the Representative of the Ministry of 
Health, Jamaica 
9h00min -  9h15min Presentation of the participants Olivia Brathwaite, MSc  
9h15min -  9h30min COFFEBREAK 
9h30min - 9h45min Introduction: General aspects of CHIK 
New Guideline content      
Dr. Roger Nasci  
9h45min -10h45min CHIK  Epidemiology & Physiopathology  Dr. Fabrice Simon 
10h45min – 11h00min Questions  
11h00min – 11h15min Introduction:  CHIK  Lab Diagnosis  Dr. Ann Powers 
11h15min – 11h30min Introduction: Aedes ae. control Dr. Roberto Barrera 
11h30min – 12h00min  Discussion, questions, and observations   
12h00min-13h00min LUNCH 
 Working Groups 
CLINICAL GROUP LABORATORY ENTOMOLOGY GROUP 
13h00min – 15h30min CHIK Case identification 
and management; cases 
discussion  
Moderators:   
Clinical case 
management Team 
Lab techniques for CHIK 
diagnosis; laboratory 
preparedness and response 
Differential diagnostics with 
other disease. 
Quality control 
Moderators: Laboratory Team 
Training session at the MOH 
Vector control Program:  
Evaluation of Vector control 
programs. 
Best practices for Aedes 
aegypti control. 
Moderators: 
Vector control Team 
15h30min – 15h45min COFFEBREAK 
15h45min–17h30min Continue working groups.   Back to the hotel (18h00) 
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Tuesday, May 29, 2012 - DENGUE 
HOUR  ACTIVITY Lecturer 
8h30min – 9h00min Dengue epidemiology  Dr. José Luis San Martin 
9h00min – 9h45min Dengue Physiopathology  Dr. Kay Tomashek 
9h45min – 10h15min Dengue laboratory diagnostics  Dr. Elizabeth Hunsperger 
10h15min – 10h30min COFFEBREAK 
 Working Groups 
CLINICAL GROUP LABORATORY GROUP ENTOMOLOGY GROUP 
10h30min – 12h30min Discussion of dengue 
clinical case management   
Moderators:   
Clinical case management 
Team 
Discussion of laboratory 




Vector control during 
outbreaks  
Moderators: 
Vector control Team 
12h30min – 13h30min LUNCH 
13h30min – 15h00min Continue working 
groups.   
Continue working groups.   Continue working groups.   
15h00min – 15h15min COFFEBREAK 
15h15min – 17h45min Country presentations 
1. Jamaica experience for dengue control (15 min). 
2. Curacao experience during dengue outbreak (15 min) 
3. Bahamas experience: Country response during DEN outbreaks: Health 
services organization and vector control (15 min). 
4. French territories’: Plan for the prevention and control of the 
introduction of the CHIKV in the French territories (15 min). 
5. Cayman island experience in vector control (15 min). 
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Wednesday, May 30, 2012 – OUTBREAK RESPONSE 
HOUR ACTIVITY Lecturer 
8h00min – 8h15min Introduction:  Risk Communication during 
outbreaks 
Monica Prado 
8h15min – 9h15min Working groups 
Draft Plan: Preparedness for outbreak control, sample movement and testing, 








Vector control group 
Rappourter: 
Monica Prado 
9h15min – 9h30min COFFEBREAK 
9h30min – 11h30min Continue Working groups 
Draft Plan: Preparedness for outbreak control, sample movement and testing, 
and response plan for CHIK in the Caribbean sub-region:  Activities and tasks. 
 Presentation and discussion of the proposal per group. 
11h30min – 12h00min Clinical group Participant 
12h00min – 12h30min Lab group Participant 
12h30min – 13h00min Vector control group Participant 
12h45min – 13h00min Closing of Training workshop Dr. Roger Nasci 
Dr. Jose Luis San martin 
Dr. Pedro Más Bermejo 
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AGENDA – CLINICAL GROUP 
Monday, May 28, 2012 - CHIKUNGUNYA  
13h00min - 13h45min CHIK case #1 Presentation and 
discussion 
Fabrice Simon 
 13h45min – 14h30min CHIK case #2 
14h30min – 15h30min CHIK case #3 
15h30min – 15h45min COFFEBREAK 
15h45min – 16h15min Presentation: How to organize the clinical services 
during CHIK outbreaks  
Fabrice Simon 
16h15min – 16h45min Presentation: How to organize the clinical services 
during DEN outbreaks. 
Gabriela Marón 
16h45min – 17h30min Discussion with participants: Organization of clinical 
services during CHIK and DEN outbreaks  
Clinical team 
Tuesday, May 29, 2012 - DENGUE 
10h30min – 11h30min DEN Clinical case #1  Presentation and 
discussion 
Kay Tomashek 
11h30min – 12h30min DEN Clinical case #2 Gabriela Maron 
12h30min – 13h30min LUNCH 
13h30min – 14h15min DEN Clinical case #3  Presentation and 
discussion 
Kay Tomashek 
14h15min – 15h00min  DEN Clinical case #4 Gabriela Maron 
15h00min – 15h30min Discussion: Main points to be included in a 
CHIK/DEN Preparedness plan – patient care 
component 
Diana Rojas 
15h30min – 15h45min Coffee break 
15h45min – 17h45min Country presentations  
Wednesday, May 30, 2012 – OUTBREAK RESPONSE 
8h00min – 11h30min Draft Plan: Preparedness for outbreak control, 
sample movement and testing, and response plan 
for Chikungunya in the Caribbean sub-region:  
expected results, indicators, Activities and tasks. 
Diana Rojas 
Fabrice Simon 
11h30min – 12h45min Presentation and discussion of the proposal per 
group. 
Participant 
12h45min – 13h00min Closing of Training workshop  
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AGENDA – LABORATORY GROUP 
Monday, May 28, 2012 - CHIKUNGUNYA  
13h00min - 13h30min Sample collection, storage and transportation for 
serology, viral isolation and molecular diagnostic  
A Powers 
13h30min – 13h45min Lab techniques for CHIK diagnosis:  Serology  A Powers 
13h45min – 14h15min Lab techniques for CHIK diagnosis:  rt-PCR A Powers 
14h15min – 14h45min Lab techniques for CHIK diagnosis:  Viral isolation A Powers 
14h45min – 15h00min Differential diagnostics with other disease A Powers 
15h00min – 15h30min COFFEBREAK 
15h30min – 17h00min Discussion: Laboratory preparedness and response 
during CHIK outbreaks  
Group 
 
Tuesday, May 29, 2012 - DENGUE 
10h30min – 11h30min Overview of dengue virus diagnostics 
 
L. Hunsperger 
11h30min – 12h00min Comparison of assays including: 
DEN Rapid test 
NS1 test 
L. Hunsperger 
12h00min – 13h30min LUNCH 
13h30min – 15h30min Discussion: Laboratory preparedness and response 
during DEN outbreaks 
Group 
15h00min – 15h30min Coffee break 




Wednesday, May 30, 2012 – OUTBREAK RESPONSE 
8h15min – 11h30min Draft Plan: Preparedness for outbreak control, 
sample movement and testing, and response plan 
for Chikungunya in the Caribbean sub-region:  
expected results, indicators, Activities and tasks. 
 
11h30min – 12h45min Presentation and discussion of the proposal per 
group. 
 
12h45min – 13h00min Closing of Training workshop  
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AGENDA – VECTOR CONTROL GROUP 
Monday, May 28, 2012 - CHIKUNGUNYA  
13h00min - 13h30min Transfer to MOH Vector office  
13h30min – 13h45min 
 
Objectives of the entomology working group  
Best practices for vector control 
Dr. Roger Nasci 
13h45min – 15h45min IVM 
Vector control organization and activities in the 
participating countries – Resource inventory 
Guided discussion based on the questionnaire 
Dr. Chris Frederickson 
Vector control Team 
15h45min – 16h00min COFFEBREAK  
16h00min – 16h15min Update on Vector surveillance techniques and 
identification of high risk areas 
Dr. Roberto Barrera 
16h15min – 18h00min Field demonstration of surveillance tools Vector control Team 
18h00min Transfer to the hotel  
 
Tuesday, May 29, 2012 - DENGUE 
10h30min – 11h00min Vector control new tools Dr. Roberto Barrera 
11h00min – 11h30min Vector control supervision, monitoring and 
evaluation program 
Dr. Chris Frederickson 
11h30min – 12h00min Vector control activities during outbreaks  Dr. Roger Nasci 
12h00min – 12h30min Discussion  
12h30min – 13h30min LUNCH 
13h30min – 15h30min Discussion: Preparedness for outbreak control 
and response for Chikungunya in the Caribbean 
sub-region: Selection of expected results & 
indicators 
Moderator: Dr. Chris 
Frederickson & Vector 
control Team 
15h30min – 15h45min Coffee break 
15h45min – 17h45min Country presentations  
 
Wednesday, May 30, 2012 – OUTBREAK RESPONSE 
8h15min – 11h30min 
 
Draft Plan: Preparedness for outbreak control, 
sample movement and testing, and response 
plan for Chikungunya in the Caribbean sub-
region:  expected results, indicators, Activities 
and tasks. 
Vector control Team 
11h30min – 12h45min Presentation and discussion of the proposal 
per group. 
 
12h45min – 13h00min Closing of Training workshop  
13h00min – 14h00min LUNCH 
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Annex 2 - List of participants 
 
Caribbean Sub-regional Training Workshop 
Introducing the new guidelines: Preparedness and Response for Chikungunya Virus Introduction in the Americas 
in the context of Dengue 
KINGSTON, JAMAICA - 28 AL 30 DE MAYO 2012 
LIST OF PARTICIPANTS 
Jamaica (HOST) (Name) (Title) Email 
Participant 1 – Clinical Management Dr. Marion Bullock DuCasse Senior Medical Officer 
(Health), Director, 
Emergency, Disaster, 
Management & Special 
Services 
mohemergency@yahoo.com  
Participant 2 - Clinical Management Dr. Audine Garrison Infectious Disease 
Consultant, HPH 
aupagar@yahoo.com 
Participant 3 - Clinical Management Dr. Hopeton Falconer Senior Medical Officer, 
Mandeville General Hospital 
hopfal@hotmail.com  
Participant 4 - Clinical Management  Dr. Stennett Dixon Medical Officer (MO 2), 
Falmouth Hospital 
dixonstenneth@hotmail.com  




Participant 6 - Vector Control Miss Sherine Huntley  Entomologist Huntleys@moh.gov.jm; 
savedsh@yahoo.com  
Participant 7 - Vector Control Mr. Everton Baker Chief Public Health Inspector evertonl.baker@gmail.com 
Participant 8 - Clinical Management  Dr. Karen Webster Medical Officer of Health, 
KSA 
kwebsterkerr@yahoo.com  
Participant 9 - Vector Control Mr. Steve Morris Chief Public Health 
Inspector, Westmoreland 
 specky250@ymail.com 
Participant 10 - Laboratory Ms. Anjoydie Harris Senior Medical Technologist, 
NPHL 
anjoydee2000@yahoo.com 
Participant 11 - Laboratory Ms. Meagon Welch-Comrie Chief Medical Technologist, 
Cornwall Regional Hospital 
karae_k@yahoo.com  
Participant 12 - Laboratory Dr. Karen Shaw  Consultant Microbiologist 
National Public Health Lab 
 Microlab2007@yahoo.com  
Participant 13 Dr. Sarah Al-Johar MOH Jamaica drsarahmayser@yahoo.com  
Participant 14 - Clinical Management  Dr. Tonia Dawkins Medical Epidemiologist, 
MOH/SERHA 
toni_d81@hotmail.com 
Participant 15 – Health Promotion Dr. Sonia Copeland Director Health Promotion & 
Protection 
copelands@moh.gov.jm  
Anguilla (Name) (Title) Email 
Participant 1 - Vector Control Mr. Ambrell Richardson Chief Environmental Officer ambrell.richardson@gov.ai  
ambrelle112@gmail.com 
Antigua & Barbuda (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Armina Nyoka Goodwin Infectious Disease Specialist drarminafernandez@cand.wag; 
winamina@hotmail.com 
Aruba (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Rollyn Reventlo Angela Family Physician dr.angela@setarnet.aw  
Participant 2 - Vector Control Dr. Dionisio Fecito 
Richardson 
Vector Control dionisio_richardson@yahoo.com 
Participant 3 - Laboratory Dr. Riemsdijk Willem Albert 
van den Berg 
 
Microbiologist riem@landslab.org  
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Bahamas (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Julien Patrick Smith  The Malaria Focal Point in 
the Ministry of Health 
juliensmith@bahamas.gov.bs 




Barbados (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Hanson Cummings Medical Registrar, Queen 
Elizabeth Hospital 
hansonmc@gmail.com 
Participant 2 - Vector Control Mr. Ronald Chapman Environmental Health 
Specialist 
ronaldchapman@yahoo.com 





Belize (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Karl Jones Clinician, from the Karl 
Heusner Memorial Hospital  
karljones2482@gmail.com 
Participant 2 - Vector Control Mr. Kim Bautista Chief Operations Officer, 
Vector Control Unit, MOH 
kbautista@health.gov.bz 
Participant 3 - Laboratory Mr. Albert Seawell Central Medical Laboratory albert_seawell@hotmail.com  
Bermuda (Name) (Title) Email 
Participant 1 - Vector Control Mr. Armell Thomas Senior Environmental Health 
Officers 
althomas@gov.bm 
St Marteen (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Grace Spencer Medical Doctor drspencer@caribserve.net  
Participant 2 - Vector Control Ms. Maria Magdalena Henry Head of Section General 
Public Health 
Maria.Henry@sintmaartengov.org  
Cayman Islands (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Kiran Kumar Alla Director of Primary Health 
Care Services/Medical 




Participant 2 - Vector Control -  Dr. Angela Harris Senior Research Officer 
(Entomology) 
angela.harris@gov.ky  
Participant 3 - Vector Control -  Dr. Alan Stephen Wheeler Deputy Director, of the 
Mosquito Research & 
Control Unit.   
alan.wheeler@gov.ky 
Curaçao (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Kenrick Berend Internist, Chief of Dept of 
Internal Medicine, St 
Elisabeth Hospital Curacao 
 
kenber2@me.com 
Dominica (Name) (Title) Email 




Participant 2 - Clinical Management Dr. Adis King Medical Officer  adiskj@hotmail.com  
Turks & Caicos (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Daryl Rae Hobbs Family Nurse Practitioner darylfnp@gmail.com 
Guadalupe - (Name) (Title) email 
Participant 1 - Vector Control Dr. Joël,  Alex, Georges, 
GUSTAVE  
In charge of the Vector 
control Unit in Guadalupe 
Joel.GUSTAVE@ars.sante.fr 
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Participant 2 - Clinical Management Dr. Jean-Loup, André 
CHAPPERT 
Epidemiology Unit (CIRE). In 
charge of plan for the 
prevention of the 
introduction of Chik in the 
FDA. 
Jean-Loup.CHAPPERT@ars.sante.fr 
Guyana (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Reyaud Rahaman Technical doctor at the 
Malaria & Vector Control 
Clinic, Ministry of Health 
 reyaudrahman@gmail.com 
Participant 2 - Laboratory Ms. Joyce White Chin Head of Department, 





Saint Lucia (Name) (Title) Email 
Participant 1 - Vector Control Ms. Louisa Wilson Environmental Health 
Officer 
l.wilson@hotmail.com  
Participant 2 - Clinical Management Dr. Christy Nathaniel Consultant, Internist christynats@yahoo.co.uk  
Participant 3 - Laboratory Ms. Semonia Altenor Lab. Technologist monastc@hotmail.com 
e3ra-longlab@yahoo.com 
St. Kitts and Nevis (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Reginald M. O’Loughlin District Medical Officer Remolo1@hotmail.com 
St. Vincent and the Grenadines (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Conrad Alford Nedd Medical Supervisor – 
Accident and Emergency 
nmmclinic@gmail.com  
Suriname (Name) (Title) Email 




Participant 2 - Vector Control Dr.Ir. Helene Hiwat – van 
Laar 
Entomologist/ acting head 
of Entomology Department 
LAB of Bureau of Public 
Health 
helenehiwat@gmail.com 
Participant 3 - Laboratory Mr. Merril Wongsokarijo Head Central Lab Bureau of 
Public Health, Central Lab 
Bureau of Public Health 
merril@bog.sr 
mer-wongso@hotmail.com 
Trinidad & Tobago (Name) (Title) Email 
Participant 1 - Clinical Management Dr. Avery Quincy Joel Hinds Epidemiologist, National 
Surveillance 
averyqjhinds@hotmail.com  
Participant 2 - Laboratory Dr. Leslie Violet Jo-anne 
Carrington 
Director National Public 
Health Laboratory  
leslie.carrington@health.gov.tt  
Participant 3 - Vector Control Dr. Mentor Melville General Manager, Primary 
Health Care, Tobago House 
of Assembly 
melvilleonline@hotmail.com  
ECC - Montserrat (Name) (Title) Email 
Participant 1 - Vector Control Mr. Trevor Howe Chief Environmental Health 
Officer 
howet@gov.ms 
CAREC  (Name) (Title) Email 
Participant 1 - Epidemiology or 
Laboratory 








Annex 3 - Technical group 
 
(Name) (Title) Email 
Dr. Fabrice Simon Professor - Department of 
Infectious diseases and Tropical 
Medicine, Laveran Military 
Hospital, France. 
simon-f@wanadoo.fr 
Dr. Gabriela Marón Clinician, Hospital Nacional de 
Niños Benjamin Bloom, El Salvador 
gabriela.maron@stjude.org  
Dr. Ann M. Powers Chief, Alphavirus Laboratory. 
Vector-Borne Diseases Division, 
CDC – Fort Collins 
ann.powers@cdc.hhs.gov  
Dr. Roger S. Nasci  Chief - Arboviral Diseases Branch,  
CDC - Ft. Collins, CO 
RNasci@cdc.gov; 
roger.nasci@cdc.hhs.gov  
Dr. Kay Tomashek Epidemiologist. CDC-Dengue 
Branch, San Juan Puerto Rico. 
kay.tomashek@cdc.hhs.gov  
Dr. Elizabeth Hunsperger Activity Chief, Serology Diagnostics 
and Research Laboratory, CDC-




Dr. Roberto Barrera Entomologist. CDC Dengue branch- 
San Juan, Puerto Rico 
roberto.barrera@cdc.hhs.gov  
Dr. Diana Patricia Rojas  Epidemiologist – Instituto Nacional 
de Salud, Colombia. 
dianarojasa@gmail.com  
Dr. Monica Prado Journalist, Social Communication 
Specialist - Brasilia, Brazil 
opsmonica@hotmail.com 
Dr. Jose Luis San Martin Dengue Regional Advisor / PAHO 
COSTA RICA 
sanmartj@cor.ops-oms.org  
Dr. Chris Frederickson Entomologist / PAHO COSTA RICA frederic@cor.ops-oms.org  
Lic. Olivia Brathwaite Influenza and other Viruses 
Specialist / PAHO HQ / USA 
 brathwaiteo@paho.org  
Dr. Pedro Mas Bermejo CD Focal Point - PAHO JAMAICA masbermep@jam.paho.org  
Mrs. Paula Miller-
Morgan 
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